Post COVID-19 condition occurs in individuals with a history of probable or confirmed SARS-
CoV-2 infection, usually 3 months from the onset of COVID-19 with symptoms that last for at …

Objective COVID-19 can rarely lead to severe illness in pediatric patients. The aim of this
study was to determine if severe outcomes in pediatric COVID-19 have changed over the …

Several databases are available to determine the burden of severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2) infection and coronavirus disease 2019 (COVID-19) …

Background Risk stratification is a cornerstone of the Pediatric Infectious Diseases Society
COVID-19 treatment guidance. This systematic review and meta-analysis aimed to define …

Importance The postacute sequelae of SARS-CoV-2 infection (PASC) has emerged as a
long-term complication in adults, but current understanding of the clinical presentation of …

Starting in late 2019, a novel coronavirus rapidly spread throughout the world, resulting in a
global pandemic. The virus was designated severe acute respiratory syndrome coronavirus …

OBJECTIVES Vaccination reduces the risk of acute coronavirus disease 2019 (COVID-19) in
children, but it is less clear whether it protects against long COVID. We estimated vaccine …

Background Data on the clinical characteristics of pediatric patients with severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) variant infection are limited. We aimed to …

Objectives Post-acute sequalae of SARS-CoV-2 infection (PASC) is not well defined in
pediatrics given its heterogeneity of presentation and severity in this population. The aim of …

The COVID-19 pandemic caused by the coronavirus 2 of the severe acute respiratory
syndrome (SARS-CoV-2) has significantly affected people around the world, leading to …